Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase I and II Clinical Study on Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases

NCT06877364 is registered in ClinicalTrials.gov with S.LAB (SOLOWAYS) as lead sponsor.

NCT NCT06877364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase I and II Clinical Study on Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases
Lead sponsor
S.LAB (SOLOWAYS)
Phase
Phase 1/2
Overall status
Completed
Start date
September 1, 2025
Completion date
November 3, 2025
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation